Organon & Co.
OGN
$8.16
-$0.285-3.38%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.29B | 6.40B | 6.41B | 6.35B | 6.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.29B | 6.40B | 6.41B | 6.35B | 6.35B |
| Cost of Revenue | 2.70B | 2.69B | 2.68B | 2.63B | 2.60B |
| Gross Profit | 3.60B | 3.72B | 3.73B | 3.72B | 3.75B |
| SG&A Expenses | 1.75B | 1.76B | 1.68B | 1.79B | 1.81B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.90B | 4.92B | 4.83B | 4.92B | 4.92B |
| Operating Income | 1.40B | 1.49B | 1.58B | 1.43B | 1.43B |
| Income Before Tax | 672.00M | 807.00M | 782.00M | 655.00M | 674.00M |
| Income Tax Expenses | -78.00M | -57.00M | -519.00M | -345.00M | -373.00M |
| Earnings from Continuing Operations | 750.00 | 864.00 | 1.30K | 1.00K | 1.05K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 750.00M | 864.00M | 1.30B | 1.00B | 1.05B |
| EBIT | 1.40B | 1.49B | 1.58B | 1.43B | 1.43B |
| EBITDA | 1.70B | 1.77B | 1.84B | 1.68B | 1.67B |
| EPS Basic | 2.91 | 3.36 | 5.07 | 3.91 | 4.10 |
| Normalized Basic EPS | 2.09 | 2.26 | 2.49 | 2.06 | 2.08 |
| EPS Diluted | 2.87 | 3.32 | 5.04 | 3.89 | 4.08 |
| Normalized Diluted EPS | 2.07 | 2.24 | 2.48 | 2.05 | 2.07 |
| Average Basic Shares Outstanding | 1.03B | 1.03B | 1.03B | 1.02B | 1.02B |
| Average Diluted Shares Outstanding | 1.04B | 1.04B | 1.03B | 1.03B | 1.03B |
| Dividend Per Share | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 |
| Payout Ratio | 39.73% | 34.38% | 22.75% | 29.60% | 27.79% |